339 related articles for article (PubMed ID: 11802534)
21. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis.
Iitaka M; Miura S; Yamanaka K; Kawasaki S; Kitahama S; Kawakami Y; Kakinuma S; Oosuga I; Wada S; Katayama S
J Clin Endocrinol Metab; 1998 Nov; 83(11):3908-12. PubMed ID: 9814467
[TBL] [Abstract][Full Text] [Related]
22. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
[TBL] [Abstract][Full Text] [Related]
23. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
[TBL] [Abstract][Full Text] [Related]
24. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring.
Luton D; Le Gac I; Vuillard E; Castanet M; Guibourdenche J; Noel M; Toubert ME; Léger J; Boissinot C; Schlageter MH; Garel C; Tébeka B; Oury JF; Czernichow P; Polak M
J Clin Endocrinol Metab; 2005 Nov; 90(11):6093-8. PubMed ID: 16118343
[TBL] [Abstract][Full Text] [Related]
25. Prediction of relapse after antithyroid drug therapy of Graves' disease: value of color Doppler sonography.
Saleh A; Cohnen M; Fürst G; Mödder U; Feldkamp J
Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):510-3. PubMed ID: 15505758
[TBL] [Abstract][Full Text] [Related]
26. Ultrasonographic thyroid volume as a reliable prognostic index of radioiodine-131 treatment outcome in Graves' disease hyperthyroidism.
Gómez-Arnaiz N; Andía E; Gumà A; Abós R; Soler J; Gómez JM
Horm Metab Res; 2003 Aug; 35(8):492-7. PubMed ID: 12953167
[TBL] [Abstract][Full Text] [Related]
27. The effect of anti-thyroid drug treatment duration on thyroid gland microvessel density and intraoperative blood loss in patients with Graves' disease.
Erbil Y; Giriş M; Salmaslioglu A; Ozluk Y; Barbaros U; Yanik BT; Kapran Y; Abbasoglu SD; Ozarmagan S
Surgery; 2008 Feb; 143(2):216-25. PubMed ID: 18242338
[TBL] [Abstract][Full Text] [Related]
28. Doppler evaluation of intrathyroid arterial resistances during preoperative treatment with Lugol's iodide solution in patients with diffuse toxic goiter.
Ansaldo GL; Pretolesi F; Varaldo E; Meola C; Minuto M; Borgonovo G; Derchi LE; Torre GC
J Am Coll Surg; 2000 Dec; 191(6):607-12. PubMed ID: 11129808
[TBL] [Abstract][Full Text] [Related]
29. Doppler ultrasonography in predicting relapse of hyperthyroidism in Graves' disease.
Varsamidis K; Varsamidou E; Mavropoulos G
Acta Radiol; 2000 Jan; 41(1):45-8. PubMed ID: 10665869
[TBL] [Abstract][Full Text] [Related]
30. Outcome of Graves' disease after antithyroid drug treatment in Taiwan.
Wang PW; Liu RT; Tung SC; Chien WY; Lu YC; Chen CH; Kuo MC; Hsieh JR; Wang ST
J Formos Med Assoc; 1998 Sep; 97(9):619-25. PubMed ID: 9795530
[TBL] [Abstract][Full Text] [Related]
31. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
[TBL] [Abstract][Full Text] [Related]
32. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment.
Vitti P; Rago T; Chiovato L; Pallini S; Santini F; Fiore E; Rocchi R; Martino E; Pinchera A
Thyroid; 1997 Jun; 7(3):369-75. PubMed ID: 9226205
[TBL] [Abstract][Full Text] [Related]
33. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
[TBL] [Abstract][Full Text] [Related]
34. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves' disease and diffuse toxic goiter.
Saleh A; Cohnen M; Fürst G; Godehardt E; Mödder U; Feldkamp J
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):32-6. PubMed ID: 11835123
[TBL] [Abstract][Full Text] [Related]
36. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
37. Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography.
Bogazzi F; Bartalena L; Brogioni S; Burelli A; Manetti L; Tanda ML; Gasperi M; Martino E
Eur J Endocrinol; 1999 May; 140(5):452-6. PubMed ID: 10229913
[TBL] [Abstract][Full Text] [Related]
38. Ten-year follow-up study of thyroid function in euthyroid patients with simple goiter or Hashimoto's thyroiditis.
Sato A; Aizawa T; Koizumi Y; Komiya I; Ichikawa K; Takemura Y; Yamada T
Intern Med; 1995 May; 34(5):371-5. PubMed ID: 7647404
[TBL] [Abstract][Full Text] [Related]
39. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy.
Fenzi G; Hashizume K; Roudebush CP; DeGroot LJ
J Clin Endocrinol Metab; 1979 Apr; 48(4):572-6. PubMed ID: 581875
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors for the Relapse of Graves' Disease Treated With Antithyroid Drugs: A Systematic Review and Meta-analysis.
Shi H; Sheng R; Hu Y; Liu X; Jiang L; Wang Z; Cui D
Clin Ther; 2020 Apr; 42(4):662-675.e4. PubMed ID: 32139177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
